Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1980-12-04
1984-09-18
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
A61K 31455
Patent
active
044724101
ABSTRACT:
A method and substances are featured for reducing the risk of incurring renal damage or failure. Substances useful in the treatment of hyperlipidemia and closely-related vascular conditions have been found to reduce or prevent renal failure. The substances most generally utilized are derivatives of phenoxyacetic acid. These substances are administered from 0.01 to 0.25% by weight of the dietary materials ingested by the host which is equivalent to 0.2 to 6.0 grams per day in man.
REFERENCES:
Edwards et al.; Med. J. Aust. (1972) 2, p. 167.
Edwards et al.; Lancet, (1973) 1, p. 1192.
Ibels et al.; British Med. Journal, pp. 552-554 (1976).
Issekutz; Canadian Journal of Physiology+Pharmocology, vol. 49 (1971), pp. 102-105.
Edwards et al.; Aust. NZJ. Med. 4:420 (1976).
Edwards, Artery; 3(2) 135-149 (1977).
Issekutz; C.A. vol. 74 (1971) 110013s.
LandOfFree
Preventing renal failure employing nicotinic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventing renal failure employing nicotinic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing renal failure employing nicotinic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793828